Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Safety, and Tolerability of Ready to Use Exenatide Once Weekly in Healthy and T2DM Subjects
NCT00894322Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Apr 2009; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00894322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894322.